Back to search
🇺🇸

United States · US · US:0074-1055_998985bb-7cd1-4e80-bd08-8fc7c503f982

EMRELIS

UNIISPL

Last synced from FDA National Drug Code directory (United States) on

Identification

ManufacturerAbbVie Inc.
CountryUS (United States)
ATC code
Dispensing
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026

Packs · 1

  • ndc11
    0074105501
    1 VIAL, SINGLE-DOSE in 1 CARTON (0074-1055-01) / 1 mL in 1 VIAL, SINGLE-DOSE

Annotations

UNII (FDA Substance ID)
976X9VXC3Z
TELISOTUZUMAB VEDOTIN
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
  "unii": {
    "unii": "976X9VXC3Z",
    "rxcui": null,
    "inchikey": null,
    "display_name": "TELISOTUZUMAB VEDOTIN",
    "substance_type": "protein",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "INTRAVENOUS",
  "spl_meta": {
    "bc04f980-3957-4e35-ab81-8ec2ffe87215": {
      "match": "brand_token",
      "title": "EMRELIS (TELISOTUZUMAB VEDOTIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ABBVIE INC.]",
      "spl_version": "3",
      "published_date": "2025-07-10"
    }
  },
  "productid": "0074-1055_998985bb-7cd1-4e80-bd08-8fc7c503f982",
  "productndc": "0074-1055",
  "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "TELISOTUZUMAB VEDOTIN",
  "proprietary_name": "EMRELIS",
  "active_ingred_unit": "mg/mL",
  "application_number": "BLA761384",
  "marketing_category": "BLA",
  "nonproprietary_name": "Telisotuzumab Vedotin",
  "start_marketing_date": "20250514",
  "active_numerator_strength": "100"
}

Access this data programmatically

Query EMRELIS and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.